Encora Therapeutics Receives FDA 510(k) Clearance for Encora X1™, a Breakthrough Wearable Device for Essential Tremor Encora Therapeutics, a leader in non-invasive neuromodulation technology, today announced that the U.S. Food…
Dave & Cheryl Duffield Foundation Provides $1.9M Grant for Yes to Care Program, a Collaboration to Improve Access to Veterinary Care Open Door Veterinary Collective has announced a $1.9 Million…
We Are All Sculptra: First-of-its-Kind Galderma Initiative to Demonstrate How Everyone Can Benefit from Sculptra’s Regenerative Properties Galderma the pure-play dermatology category leader, today unveiled We Are All Sculptra, a unique…
Head & Shoulders Launches BARE Itchy Scalp Relief Serum to Prevent Recurring Itch and Flakes Between Washes Head & Shoulders, the world’s #1 anti-dandruff shampoo, introduces Head & Shoulders BARE Itchy…
AstraZeneca awards $3.4 million for programs to improve access to healthcare for patients across the US AstraZeneca has proudly awarded $3.4 million to nonprofit organizations in the US through its Accelerate…
New Sensodyne Clinical Repair Toothpaste Launches with Breakthrough Formula for Rapid, Clinically Proven Sensitivity Relief The No. 1 dentist-recommended brand for sensitive teeth has launched Sensodyne Clinical Repair, its newest option…
Vynca Appoints Veteran Palliative Care Leader Jill Schwartz-Chevlin, MD, MBA, FACP, as Chief Medical Officer Vynca, a health technology and services company supporting individuals with serious illness and complex needs,…
Vida Health Expands Cardiometabolic Care to Include MASH, Addressing a Fast-Growing Obesity-Related Cost Driver Vida Health, a virtual, personalized obesity care provider that helps patients manage obesity, diabetes, and related…
1,600+ Pharmacies Using EQUIPP Copilot™ Report Up to 4x Revenue Boost, Close More Care Gaps Pharmacy Quality Solutions (PQS), an Innovaccer company and leader in pharmacy-payer performance technology, today announced significant…
Coya Therapeutics to Host Webinar with Leading Medical Experts on Amyotrophic Lateral Sclerosis (ALS) Drug Development, Patient Landscape, and Ongoing Clinical Trial Coya Therapeutics, Inc a clinical-stage biotechnology company developing biologics…
Evommune Announces Positive Top-line Data from Phase 2a Proof-of-Concept Trial of EVO301 in Moderate-to-Severe Atopic Dermatitis Evommune, Inc. a clinical-stage biotechnology company developing innovative therapies that target key drivers of…
AlphaLab Selects 20 Startups for 2026 Cohort Embedding Intelligence Into Industry AlphaLab, the accelerator of Innovation Works helping entrepreneurs accelerate their path to market, has selected 20 companies to join its 2026…